The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Priorities for a New FDA
Abstract
This Viewpoint outlines new priorities of the US Food and Drug Administration (FDA).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The findings were first benchmarked against results from the STEP-HFpEF DM and SUMMIT trials.
“these findings were first benchmarked against results from the STEP-HFpEF DM and SUMMIT trials.9-11,55”
From Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction (2025) · cites this paper as [55]
Regulatory agencies and guideline committees have emphasized the need for further evidence for major clinical outcomes in heart failure.
“Because regulatory agencies and guideline committees have emphasized the need for further evidence for major clinical outcomes in heart failure”
From Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction (2025) · cites this paper as [55]
Citations
Cites
Prevalence and Trends of Developmental Disabilities among Children in the United States: 2009–2017
Zablotsky, B., Black, L. I., Maenner, M. J., Schieve, L. A., Danielson, M. L., Bitsko, R. H., Blumberg, S. J., Kogan, M. D., & Boyle, C. A. (2019) · Pediatrics · doi:10.1542/peds.2019-0811 · Cited by 1,217
Flagged first, then by citations
Research works printed but not linked: 5
- Sharma, 2025, Reviewing the safety of our foods and drugs: an urgent need for a comprehensive reevaluation by FDA of talc in the American food and drug supply., J Acad Public Health, 10.70542/rcj-japh-art-16avrw · DOI
- Spence, 2015, On the psychological impact of food colour., Flavour (Lond), 4, 21, 10.1186/s13411-015-0031-3 · DOI · Paper page
- Prasad, 2015, Hard-wired bias: how even double-blind, randomized controlled trials can be skewed from the start., Mayo Clin Proc, 90, 1171, 10.1016/j.mayocp.2015.05.006 · DOI
- Wang, 2023, Emulation of randomized clinical trials with nonrandomized database analyses: results of 32 clinical trials., JAMA, 329, 1376, 10.1001/jama.2023.4221 · DOI · Paper page
- Barosa, 2025, The cost of emulated target trials: is real-world data cheaper than randomized studies?, Eur J Clin Invest, 10.1111/eci.70035 · DOI
Cited by
Sorted by citations
Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction
Krüger, N., Schneeweiss, S., Fuse, K., Matseyko, S., Sreedhara, S. K., Hahn, G., Schunkert, H., & Wang, S. V. (2025) · JAMA · doi:10.1001/jama.2025.14092 · Cited by 66
Metadata
- Authors
- Makary, M. A., & Prasad, V.
- Affiliations
- US Food and Drug Administration, Silver Spring, Maryland
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2025-08-19
- Volume
- 334
- Issue
- 7
- Pages
- 565
- ISSN
- 0098-7484
- Cited by
- 43
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
